These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6355720

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Polytherapy in multibacillary leprosy patients in Nepal.
    Samuel NM, Samual S, Fairbairn T, Adiga RB.
    Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403
    [No Abstract] [Full Text] [Related]

  • 3. Recent trends in chemotherapy of leprosy.
    Parikh DA, Maniar JK, Parikh AC, Ganapati R.
    J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chemotherapy of leprosy for control programmes: scientific basis and practical application.
    Rees RJ.
    Lepr Rev; 1983 Jun; 54(2):81-7. PubMed ID: 6888143
    [No Abstract] [Full Text] [Related]

  • 6. Multi-drug therapy in leprosy: an effective method of control.
    Indian J Lepr; 1984 Jun; 56(1):102-12. PubMed ID: 6548238
    [Abstract] [Full Text] [Related]

  • 7. Treatment of leprosy with rifampicin and isoprodian (L73A).
    Terencio de las Aguas J.
    Lepr Rev; 1975 Jun; 46(2 Suppl):165-8. PubMed ID: 1100956
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
    Rohde R.
    Lepr Rev; 1975 Jun; 46(2 Suppl):199-205. PubMed ID: 1100961
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
    Innami S, Leguizamón OR, Alvarenga AE.
    Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
    [No Abstract] [Full Text] [Related]

  • 11. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
    Krenzien HN.
    Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of treatment of lepromatous leprosy patients in the Netherlands.
    Faber WR, Leiker DL.
    Dermatologica; 1979 Jun; 158(1):46-54. PubMed ID: 367843
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
    Colin M, de Montaigne E.
    Med Trop (Mars); 1980 Jun; 40(2):157-9. PubMed ID: 6991851
    [Abstract] [Full Text] [Related]

  • 14. Combined therapy in leprosy.
    Gatti JC.
    Lepr Rev; 1975 Jun; 46(2 Suppl):155-60. PubMed ID: 1100955
    [No Abstract] [Full Text] [Related]

  • 15. [Chemotherapy of leprosy. II. Sulfones and sulfonamides].
    Leiker DL.
    Ned Tijdschr Geneeskd; 1980 Jan 12; 124(2):46-8. PubMed ID: 7374822
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice.
    Shepard CC.
    Int J Lepr Other Mycobact Dis; 1976 Jan 12; 44(1-2):135-9. PubMed ID: 945234
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of Hansen's disease.
    Alto WA.
    Am Fam Physician; 2002 Apr 01; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.